Navigating the Complexities: Health Technology Assessment for Rare Diseases
The Commercial Eyes Access team recently had the opportunity to attend a seminar ‘Should we use a different HTA process for rare disease treatments?’ organised by Melbourne University, led by…
Understanding Patient Perspectives: The First in our Ongoing Patient Survey Series
In recent years there has been a shift in healthcare towards a more ‘patient-centric’ approach. However despite this shift, there remains a limited understanding of patients’ perspectives. Here we present…
Social workers provide vital support in the healthcare cycle, helping with treatment plans and being a critical communicative link between patients and HCPs. This link can be used to help…
Identifying the right thought leader is critical in Medical Communications, and with the shift to omnichannel marketing, these leaders are finding new mediums to engage and influence scientific…
Pricing & policy decisions: Do you have an external or company only view?
The effectiveness of one intervention compared to another, also known as the treatment effect, is frequently a key consideration when assessing the cost-effectiveness of alternative therapeutic interventions for economic…
We really do pride ourselves on efficiency and quality. We aim to respond and provide quality information in a timely manner, as we understand the urgency of these enquiries and…